Titel

Merkliste
1 Ergebnisse

Overall survival (OS) by frailty (frail vs. intermediate or..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/figure/Overall_survival_OS_by_frailty_frail_vs_intermediate_or_fit_46_months_vs_not_reached_HR_1_94_95_CI_0_89_4_2_p_0_094_/18175686. , 2022

Link: https://doi.org/10.1371/journal.pone.0262388.g002

RT Journal
T1 <Title>Overall survival (OS) by frailty (frail vs. intermediate or fit): (46 months vs. not reached, HR:1.94, 95% CI 0.89–4.2, p = 0.094)</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_18175686&Exemplar=1&LAN=DE
				
A1 Faouzi Djebbari (6004379)
A1 Alexandros Rampotas (11933847)
A1 Fotios Panitsas (11933850)
A1 Wen Yuen Lim (11933853)
A1 Charlotte Lees (5864870)
A1 Ismini Tsagkaraki (11933856)
A1 Ana Rita Gomes (9089092)
A1 Steve Prideaux (11933859)
A1 Lucia Chen (7349012)
A1 Catherine Prodger (11933862)
A1 Akhil Khera (11933865)
A1 Nicola Gray (1590448)
A1 Lauren Ellis (11933868)
A1 Gina Sangha (11933871)
A1 Toby A. Eyre (8479401)
A1 Sally Moore (6078818)
A1 Jaimal Kothari (6078821)
A1 Karthik Ramasamy (795392)
YR 2022
K1 Medicine
K1 Physiology
K1 Pharmacology
K1 Biotechnology
K1 Developmental Biology
K1 Cancer
K1 Mental Health
K1 Hematology
K1 Infectious Diseases
K1 overall response rate
K1 focus towards reducing
K1 enable meaningful comparisons
K1 89 &# 8211
K1 clinical trial setting
K1 clinical outcomes included
K1 patients treated exclusively
K1 proven prognostic values
K1 higher incidence rate
K1 based vcd therapy
K1 revised myeloma co
K1 worse ae outcomes
K1 individualise treatment decisions
K1 61 &# 8211
K1 myeloma risk profile
K1 shorter median os
K1 clinical outcomes according
K1 frail patients compared
K1 treating frail patients
K1 os )
K1 progression
K1 treating fit patients
K1 1 %)
K1 patients
K1 8 %)
K1 orr
K1 46 months vs
K1 high risk cohort
K1 comparable across subgroups
K1 high risk real
K1 worse os
K1 clinical practice
K1 100 patients
K1 prognostic value
K1 g3 ae
K1 duration therapy
K1 8 vs
K1 mci )
K1 total cohort
K1 large cohort
K1 cohort demonstrated
JF https://figshare.com/articles/figure/Overall_survival_OS_by_frailty_frail_vs_intermediate_or_fit_46_months_vs_not_reached_HR_1_94_95_CI_0_89_4_2_p_0_094_/18175686
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0262388.g002
DO https://doi.org/10.1371/journal.pone.0262388.g002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)